{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:39:43Z","timestamp":1768826383989,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.cgh.2015.09.013","type":"journal-article","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T17:42:09Z","timestamp":1443202929000},"page":"220-225.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Rosacea, Use of Tetracycline, and Risk of Incident Inflammatory Bowel Disease in Women"],"prefix":"10.1016","volume":"14","author":[{"given":"Wen-Qing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunyoung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaowei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abrar A.","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2015.09.013_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1468-3083.2010.03751.x","article-title":"Rosacea: global diversity and optimized outcome\u2014proposed international consensus from the Rosacea International Expert Group","volume":"25","author":"Elewski","year":"2011","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2015.09.013_bib2","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jaad.2013.04.045","article-title":"New insights into rosacea pathophysiology: a review of recent findings","volume":"69","author":"Steinhoff","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.cgh.2015.09.013_bib3","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/jid.2014.148","article-title":"Effect of tetracyclines on the development of vascular disease in veterans with acne or rosacea: a retrospective cohort study","volume":"134","author":"Dosal","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.cgh.2015.09.013_bib4","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/jdv.12234","article-title":"Rosacea and cardiovascular risk factors: a case control study","volume":"28","author":"Duman","year":"2014","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.cgh.2015.09.013_bib5","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1038\/jid.2013.225","article-title":"Risk of rosacea in patients with diabetes using insulin or oral antidiabetic drugs","volume":"133","author":"Spoendlin","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.cgh.2015.09.013_bib6","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/bjc.2015.217","article-title":"Personal history of rosacea and risk of incident cancer among women in the United States","volume":"113","author":"Li","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cgh.2015.09.013_bib7","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2015.09.013_bib8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","article-title":"Inflammatory bowel disease: cause and immunobiology","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2015.09.013_bib9","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/annrheumdis-2012-202143","article-title":"Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women","volume":"72","author":"Li","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2015.09.013_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000324226","volume":"222","author":"Wakabayashi","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.cgh.2015.09.013_bib11","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1002\/ibd.21643","article-title":"Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: experience from a consecutive cohort of inflammatory bowel disease patients","volume":"17","author":"Baumgart","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2015.09.013_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2340\/0001555580130133","article-title":"Rosacea fulminans in a patient with Crohn's disease: a case report and review of the literature","volume":"80","author":"Romiti","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cgh.2015.09.013_bib13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1600-0625.2008.00753.x","article-title":"Granulomatous rosacea and Crohn's disease in a patient homozygous for the Crohn-associated NOD2\/CARD15 polymorphism R702W","volume":"17","author":"van Steensel","year":"2008","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.cgh.2015.09.013_bib14","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/ajg.2010.124","article-title":"Isotretinoin use and the risk of inflammatory bowel disease: a case-control study","volume":"105","author":"Crockett","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.09.013_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/ajg.2014.8","article-title":"Isotretinoin and risk of inflammatory bowel disease: a French nationwide study","volume":"109","author":"Racine","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.09.013_bib16","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1038\/ajg.2010.303","article-title":"Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease","volume":"105","author":"Margolis","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.09.013_bib17","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1038\/ajg.2009.417","article-title":"Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study","volume":"104","author":"Bernstein","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.09.013_bib18","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1136\/gutjnl-2011-301574","article-title":"Geographical variation and incidence of inflammatory bowel disease among US women","volume":"61","author":"Khalili","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2015.09.013_bib19","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0016-5085(98)70421-4","article-title":"Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival","volume":"114","author":"Loftus","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2015.09.013_bib20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/gut.46.3.336","article-title":"Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival","volume":"46","author":"Loftus","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2015.09.013_bib21","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/jid.2015.53","article-title":"Assessment of the genetic basis of rosacea by genome-wide association study","volume":"135","author":"Chang","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.cgh.2015.09.013_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/ng.3176","article-title":"High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis","volume":"47","author":"Goyette","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.cgh.2015.09.013_bib23","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/bjd.12734","article-title":"The association between psychiatric diseases, psychotropic drugs and the risk of incident rosacea","volume":"170","author":"Spoendlin","year":"2014","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2015.09.013_bib24","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2013.04.043","article-title":"Rosacea: current state of epidemiology","volume":"69","author":"Tan","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.cgh.2015.09.013_bib25","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/ajg.2014.246","article-title":"Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis","volume":"109","author":"Ungaro","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2015.09.013_bib26","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/cncr.29216","article-title":"Teenage acne and cancer risk in US women: a prospective cohort study","volume":"121","author":"Zhang","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2015.09.013_bib27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12385","article-title":"An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes","volume":"169","author":"Tan","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cgh.2015.09.013_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356515012999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356515012999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:19:12Z","timestamp":1761542352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356515012999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1542356515012999"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2015.09.013","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rosacea, Use of Tetracycline, and Risk of Incident Inflammatory Bowel Disease in Women","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2015.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}